Skip to content

Drug interactions

Netupitant-palonosetron + Voxelotor

Severity: Moderate

Netupitant-palonosetron and Voxelotor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Voxelotor inhibits CYP3A4 and can raise exposure to CYP3A substrates such as netupitant. The clinical consequence is likely modest, with potentially more netupitant-related adverse effects.

What this interaction means in plain words

Netupitant-palonosetron and Voxelotor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Netupitant-palonosetron belongs to Gastrointestinal Tract; Voxelotor belongs to Miscellaneous.

Evidence level: Low

Why it happens

Voxelotor inhibits CYP3A4, decreasing netupitant metabolism.

What to do

Monitor for netupitant adverse effects such as headache, constipation and fatigue. No routine dose change is required for a short antiemetic course.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Voxelotor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Voxelotor?

MediHelp rates the interaction as moderate. Netupitant-palonosetron and Voxelotor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Voxelotor inhibits CYP3A4 and can raise exposure to CYP3A substrates such as netupitant. The clinical consequence is likely modest, with potentially more netupitant-related adverse effects.

How serious is the interaction between Netupitant-palonosetron and Voxelotor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for netupitant adverse effects such as headache, constipation and fatigue. No routine dose change is required for a short antiemetic course.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in